-
1
-
-
0024334289
-
Decay-accelerating factor: biochemistry, molecular biology, and function
-
Lublin DM, Atkinson JP. Decay-accelerating factor: biochemistry, molecular biology, and function. Annu Rev Immunol 1989; 7:35.
-
(1989)
Annu Rev Immunol
, vol.7
, pp. 35
-
-
Lublin, D.M.1
Atkinson, J.P.2
-
2
-
-
14244257449
-
The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo
-
Liu J, Miwa T, Hilliard B, Chen Y, Lambris JD, Wells AD, Song WC. The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo. J Exp Med 2005; 201:567.
-
(2005)
J Exp Med
, vol.201
, pp. 567
-
-
Liu, J.1
Miwa, T.2
Hilliard, B.3
Chen, Y.4
Lambris, J.D.5
Wells, A.D.6
Song, W.C.7
-
3
-
-
19344364971
-
Decay-accelerating factor modulates induction of T cell immunity
-
Heeger PS, Lalli PN, Lin F, Valujskikh A, Liu J, Muqim N, Xu Y, Medof ME. Decay-accelerating factor modulates induction of T cell immunity. J Exp Med 2005; 201:1523.
-
(2005)
J Exp Med
, vol.201
, pp. 1523
-
-
Heeger, P.S.1
Lalli, P.N.2
Lin, F.3
Valujskikh, A.4
Liu, J.5
Muqim, N.6
Xu, Y.7
Medof, M.E.8
-
4
-
-
33747697067
-
Complement regulatory proteins and autoimmunity
-
Song WC. Complement regulatory proteins and autoimmunity. Autoimmunity 2006; 39:403.
-
(2006)
Autoimmunity
, vol.39
, pp. 403
-
-
Song, W.C.1
-
5
-
-
32044432615
-
Membrane complement regulatory proteins
-
Kim DD, Song WC. Membrane complement regulatory proteins. Clin Immunol 2006; 118:127.
-
(2006)
Clin Immunol
, vol.118
, pp. 127
-
-
Kim, D.D.1
Song, W.C.2
-
6
-
-
0035451680
-
Increased susceptibility of decay-accelerating factor deficient mice to anti-glomerular basement membrane glomerulonephritis
-
Sogabe H, Nangaku M, Ishibashi Y et al. Increased susceptibility of decay-accelerating factor deficient mice to anti-glomerular basement membrane glomerulonephritis. J Immunol 2001; 167:2791.
-
(2001)
J Immunol
, vol.167
, pp. 2791
-
-
Sogabe, H.1
Nangaku, M.2
Ishibashi, Y.3
-
7
-
-
0036841116
-
Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection
-
Lin F, Kaminski HJ, Conti-Fine BM, Wang W, Richmonds C, Medof ME. Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection. J Clin Invest 2002; 110:1269.
-
(2002)
J Clin Invest
, vol.110
, pp. 1269
-
-
Lin, F.1
Kaminski, H.J.2
Conti-Fine, B.M.3
Wang, W.4
Richmonds, C.5
Medof, M.E.6
-
8
-
-
0036735306
-
Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice
-
Miwa T, Maldonado MA, Zhou L et al. Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice. Am J Pathol 2002; 161:1077.
-
(2002)
Am J Pathol
, vol.161
, pp. 1077
-
-
Miwa, T.1
Maldonado, M.A.2
Zhou, L.3
-
9
-
-
0035873190
-
Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice
-
Sekine H, Reilly CM, Molano ID et al. Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice. J Immunol 2001; 166:6444.
-
(2001)
J Immunol
, vol.166
, pp. 6444
-
-
Sekine, H.1
Reilly, C.M.2
Molano, I.D.3
-
10
-
-
0036467412
-
Complement C4 is protective for lupus disease independent of C3
-
Einav S, Pozdnyakova OO, Ma M, Carroll MC. Complement C4 is protective for lupus disease independent of C3. J Immunol 2002; 168:1036.
-
(2002)
J Immunol
, vol.168
, pp. 1036
-
-
Einav, S.1
Pozdnyakova, O.O.2
Ma, M.3
Carroll, M.C.4
-
11
-
-
34247842905
-
Decay-accelerating factor ameliorates systemic autoimmune disease in MRL/lpr mice via both complement-dependent and -independent mechanisms
-
Miwa T, Maldonado MA, Zhou L, Yamada K, Gilkeson GS, Eisenberg RA, Song WC. Decay-accelerating factor ameliorates systemic autoimmune disease in MRL/lpr mice via both complement-dependent and -independent mechanisms. Am J Pathol 2007; 170:1258.
-
(2007)
Am J Pathol
, vol.170
, pp. 1258
-
-
Miwa, T.1
Maldonado, M.A.2
Zhou, L.3
Yamada, K.4
Gilkeson, G.S.5
Eisenberg, R.A.6
Song, W.C.7
-
12
-
-
0030635831
-
Effects of mercury on the immune system
-
Pollard KM, Hultman P. Effects of mercury on the immune system. Met Ions Biol Syst 1997; 34:421.
-
(1997)
Met Ions Biol Syst
, vol.34
, pp. 421
-
-
Pollard, K.M.1
Hultman, P.2
-
14
-
-
0029583642
-
Murine mercury-induced autoimmunity: the role of T-helper cells
-
Hultman P, Johansson U, Dagnaes-Hansen F. Murine mercury-induced autoimmunity: the role of T-helper cells. J Autoimmun 1995; 8:809.
-
(1995)
J Autoimmun
, vol.8
, pp. 809
-
-
Hultman, P.1
Johansson, U.2
Dagnaes-Hansen, F.3
-
15
-
-
0025735385
-
IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride
-
Ochel M, Vohr HW, Pfeiffer C, Gleichmann E. IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride. J Immunol 1991; 146:3006.
-
(1991)
J Immunol
, vol.146
, pp. 3006
-
-
Ochel, M.1
Vohr, H.W.2
Pfeiffer, C.3
Gleichmann, E.4
-
16
-
-
0031859079
-
The prototypic Th2 autoimmunity induced by mercury is dependent on IFN-gamma and not Th1/Th2 imbalance
-
Kono DH, Balomenos D, Pearson DL, Park MS, Hildebrandt B, Hultman P, Pollard KM. The prototypic Th2 autoimmunity induced by mercury is dependent on IFN-gamma and not Th1/Th2 imbalance. J Immunol 1998; 161:234.
-
(1998)
J Immunol
, vol.161
, pp. 234
-
-
Kono, D.H.1
Balomenos, D.2
Pearson, D.L.3
Park, M.S.4
Hildebrandt, B.5
Hultman, P.6
Pollard, K.M.7
-
18
-
-
6344275147
-
Costimulation requirements of induced murine systemic autoimmune disease
-
Pollard KM, Arnush M, Hultman P, Kono DH. Costimulation requirements of induced murine systemic autoimmune disease. J Immunol 2004; 173:5880.
-
(2004)
J Immunol
, vol.173
, pp. 5880
-
-
Pollard, K.M.1
Arnush, M.2
Hultman, P.3
Kono, D.H.4
-
19
-
-
77955148831
-
Decay-accelerating factor 1 (Daf1) deficiency exacerbates xenobiotic-induced autoimmunity
-
Toomey CB, Cauvi DM, Song WC, Pollard KM. Decay-accelerating factor 1 (Daf1) deficiency exacerbates xenobiotic-induced autoimmunity. Immunology 2010; 131:99.
-
(2010)
Immunology
, vol.131
, pp. 99
-
-
Toomey, C.B.1
Cauvi, D.M.2
Song, W.C.3
Pollard, K.M.4
-
21
-
-
0025011972
-
Subnucleosome structures as substrates in enzyme-linked immunosorbent assays
-
Burlingame RW, Rubin RL. Subnucleosome structures as substrates in enzyme-linked immunosorbent assays. J Immunol Methods 1990; 134:187.
-
(1990)
J Immunol Methods
, vol.134
, pp. 187
-
-
Burlingame, R.W.1
Rubin, R.L.2
-
22
-
-
0028833417
-
Analysis of the autoantibody response to fibrillarin in human disease and murine models of autoimmunity
-
Takeuchi K, Turley SJ, Tan EM, Pollard KM. Analysis of the autoantibody response to fibrillarin in human disease and murine models of autoimmunity. J Immunol 1995; 154:961.
-
(1995)
J Immunol
, vol.154
, pp. 961
-
-
Takeuchi, K.1
Turley, S.J.2
Tan, E.M.3
Pollard, K.M.4
-
23
-
-
0032704845
-
Characterization of mouse DAF on transfectant cells using monoclonal antibodies which recognize different epitopes
-
Ohta R, Imai M, Fukuoka Y, Miwa T, Okada N, Okada H. Characterization of mouse DAF on transfectant cells using monoclonal antibodies which recognize different epitopes. Microbiol Immunol 1999; 43:1045.
-
(1999)
Microbiol Immunol
, vol.43
, pp. 1045
-
-
Ohta, R.1
Imai, M.2
Fukuoka, Y.3
Miwa, T.4
Okada, N.5
Okada, H.6
-
24
-
-
0034776676
-
Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies
-
Lin F, Fukuoka Y, Spicer A, Ohta R, Okada N, Harris CL, Emancipator SN, Medof ME. Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies. Immunology 2001; 104:215.
-
(2001)
Immunology
, vol.104
, pp. 215
-
-
Lin, F.1
Fukuoka, Y.2
Spicer, A.3
Ohta, R.4
Okada, N.5
Harris, C.L.6
Emancipator, S.N.7
Medof, M.E.8
-
25
-
-
0034781903
-
Characterization of glycosylphosphatidylinositol-anchored decay accelerating factor (GPI-DAF) and transmembrane DAF gene expression in wild-type and GPI-DAF gene knockout mice using polyclonal and monoclonal antibodies with dual or single specificity
-
Miwa T, Sun X, Ohta R, Okada N, Harris CL, Morgan BP, Song WC. Characterization of glycosylphosphatidylinositol-anchored decay accelerating factor (GPI-DAF) and transmembrane DAF gene expression in wild-type and GPI-DAF gene knockout mice using polyclonal and monoclonal antibodies with dual or single specificity. Immunology 2001; 104:207.
-
(2001)
Immunology
, vol.104
, pp. 207
-
-
Miwa, T.1
Sun, X.2
Ohta, R.3
Okada, N.4
Harris, C.L.5
Morgan, B.P.6
Song, W.C.7
-
26
-
-
0035710229
-
An overview of real-time quantitative PCR: applications to quantify cytokine gene expression
-
Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 2001; 25:386.
-
(2001)
Methods
, vol.25
, pp. 386
-
-
Giulietti, A.1
Overbergh, L.2
Valckx, D.3
Decallonne, B.4
Bouillon, R.5
Mathieu, C.6
-
27
-
-
33748501922
-
Constitutive expression of murine decay-accelerating factor 1 is controlled by the transcription factor sp1
-
Cauvi DM, Cauvi G, Pollard KM. Constitutive expression of murine decay-accelerating factor 1 is controlled by the transcription factor sp1. J Immunol 2006; 177:3837.
-
(2006)
J Immunol
, vol.177
, pp. 3837
-
-
Cauvi, D.M.1
Cauvi, G.2
Pollard, K.M.3
-
28
-
-
2442686871
-
Recombinant cobra venom factor
-
Vogel CW, Fritzinger DC, Hew BE, Thorne M, Bammert H. Recombinant cobra venom factor. Mol Immunol 2004; 41:191.
-
(2004)
Mol Immunol
, vol.41
, pp. 191
-
-
Vogel, C.W.1
Fritzinger, D.C.2
Hew, B.E.3
Thorne, M.4
Bammert, H.5
-
29
-
-
33644825236
-
Role of complement and B lymphocytes in Sjögren's syndrome-like autoimmune exocrinopathy of NOD.B10-H2b mice
-
Nguyen C, Cornelius J, Singson E, Killedar S, Cha S, Peck AB. Role of complement and B lymphocytes in Sjögren's syndrome-like autoimmune exocrinopathy of NOD.B10-H2b mice. Mol Immunol 2006; 43:1332.
-
(2006)
Mol Immunol
, vol.43
, pp. 1332
-
-
Nguyen, C.1
Cornelius, J.2
Singson, E.3
Killedar, S.4
Cha, S.5
Peck, A.B.6
-
30
-
-
33747629735
-
The role of complement in autoimmune renal disease
-
Seelen MA, Daha MR. The role of complement in autoimmune renal disease. Autoimmunity 2006; 39:411.
-
(2006)
Autoimmunity
, vol.39
, pp. 411
-
-
Seelen, M.A.1
Daha, M.R.2
-
31
-
-
33747724590
-
Complement deficiencies in humans and animals: links to autoimmunity
-
Lewis MJ, Botto M. Complement deficiencies in humans and animals: links to autoimmunity. Autoimmunity 2006; 39:367.
-
(2006)
Autoimmunity
, vol.39
, pp. 367
-
-
Lewis, M.J.1
Botto, M.2
-
32
-
-
0033990632
-
The role of complement in B cell activation and tolerance
-
Carroll MC. The role of complement in B cell activation and tolerance. Adv Immunol 2000; 74:61.
-
(2000)
Adv Immunol
, vol.74
, pp. 61
-
-
Carroll, M.C.1
-
33
-
-
2542505506
-
The role of complement in the development of systemic lupus erythematosus
-
Manderson AP, Botto M, Walport MJ. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 2004; 22:431.
-
(2004)
Annu Rev Immunol
, vol.22
, pp. 431
-
-
Manderson, A.P.1
Botto, M.2
Walport, M.J.3
-
34
-
-
0031778836
-
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
-
Botto M, Dell'Agnola C, Bygrave AE et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998; 19:56.
-
(1998)
Nat Genet
, vol.19
, pp. 56
-
-
Botto, M.1
Dell'Agnola, C.2
Bygrave, A.E.3
-
35
-
-
0036499075
-
C1q deficiency and autoimmunity: the effects of genetic background on disease expression
-
Mitchell DA, Pickering MC, Warren J, Fossati-Jimack L, Cortes-Hernandez J, Cook HT, Botto M, Walport MJ. C1q deficiency and autoimmunity: the effects of genetic background on disease expression. J Immunol 2002; 168:2538.
-
(2002)
J Immunol
, vol.168
, pp. 2538
-
-
Mitchell, D.A.1
Pickering, M.C.2
Warren, J.3
Fossati-Jimack, L.4
Cortes-Hernandez, J.5
Cook, H.T.6
Botto, M.7
Walport, M.J.8
-
36
-
-
84903184153
-
Complement and systemic lupus erythematosus
-
Walport MJ. Complement and systemic lupus erythematosus. Arthritis Res 2002; 4(Suppl 3):S279.
-
(2002)
Arthritis Res
, vol.4
, Issue.SUPPL. 3
-
-
Walport, M.J.1
-
37
-
-
0032211714
-
A critical role for complement in maintenance of self-tolerance
-
Prodeus AP, Goerg S, Shen LM, Pozdnyakova OO, Chu L, Alicot EM, Goodnow CC, Carroll MC. A critical role for complement in maintenance of self-tolerance. Immunity 1998; 9:721.
-
(1998)
Immunity
, vol.9
, pp. 721
-
-
Prodeus, A.P.1
Goerg, S.2
Shen, L.M.3
Pozdnyakova, O.O.4
Chu, L.5
Alicot, E.M.6
Goodnow, C.C.7
Carroll, M.C.8
-
38
-
-
0036681645
-
A role for the Cr2 gene in modifying autoantibody production in systemic lupus erythematosus
-
Wu X, Jiang N, Deppong C, Singh J, Dolecki G, Mao D, Morel L, Molina HD. A role for the Cr2 gene in modifying autoantibody production in systemic lupus erythematosus. J Immunol 2002; 169:1587.
-
(2002)
J Immunol
, vol.169
, pp. 1587
-
-
Wu, X.1
Jiang, N.2
Deppong, C.3
Singh, J.4
Dolecki, G.5
Mao, D.6
Morel, L.7
Molina, H.D.8
-
39
-
-
1542619243
-
Decay-accelerating factor deficiency increases susceptibility to dextran sulfate sodium-induced colitis: role for complement in inflammatory bowel disease
-
Lin F, Spencer D, Hatala DA, Levine AD, Medof ME. Decay-accelerating factor deficiency increases susceptibility to dextran sulfate sodium-induced colitis: role for complement in inflammatory bowel disease. J Immunol 2004; 172:3836.
-
(2004)
J Immunol
, vol.172
, pp. 3836
-
-
Lin, F.1
Spencer, D.2
Hatala, D.A.3
Levine, A.D.4
Medof, M.E.5
-
40
-
-
0029963341
-
Distinct regulatory roles of lymphocyte costimulatory pathways on T helper type-2 mediated autoimmune disease
-
Biancone L, Andres G, Ahn H et al. Distinct regulatory roles of lymphocyte costimulatory pathways on T helper type-2 mediated autoimmune disease. J Exp Med 1996; 183:1473.
-
(1996)
J Exp Med
, vol.183
, pp. 1473
-
-
Biancone, L.1
Andres, G.2
Ahn, H.3
-
41
-
-
0035881259
-
Resistance to xenobiotic-induced autoimmunity maps to chromosome 1
-
Kono DH, Park MS, Szydlik A, Haraldsson KM, Kuan JD, Pearson DL, Hultman P, Pollard KM. Resistance to xenobiotic-induced autoimmunity maps to chromosome 1. J Immunol 2001; 167:2396.
-
(2001)
J Immunol
, vol.167
, pp. 2396
-
-
Kono, D.H.1
Park, M.S.2
Szydlik, A.3
Haraldsson, K.M.4
Kuan, J.D.5
Pearson, D.L.6
Hultman, P.7
Pollard, K.M.8
-
42
-
-
84857745288
-
Decay-accelerating factor (DAF) deficiency in C57BL/6 mice causes spontaneous age-related autoimmune dermatitis and exacerbates contact hypersensivity
-
Liu J, Miwa T, Song WC. Decay-accelerating factor (DAF) deficiency in C57BL/6 mice causes spontaneous age-related autoimmune dermatitis and exacerbates contact hypersensivity. Mol Immunol 2007; 44:208.
-
(2007)
Mol Immunol
, vol.44
, pp. 208
-
-
Liu, J.1
Miwa, T.2
Song, W.C.3
-
44
-
-
0025347074
-
Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 5′-exon
-
Wetsel RA, Fleischer DT, Haviland DL. Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 5′-exon. J Biol Chem 1990; 265:2435.
-
(1990)
J Biol Chem
, vol.265
, pp. 2435
-
-
Wetsel, R.A.1
Fleischer, D.T.2
Haviland, D.L.3
-
45
-
-
34547610474
-
Structural and functional characterization of a novel T cell receptor co-regulatory protein complex, CD97-CD55
-
Abbott RJ, Spendlove I, Roversi P et al. Structural and functional characterization of a novel T cell receptor co-regulatory protein complex, CD97-CD55. J Biol Chem 2007; 282:22023.
-
(2007)
J Biol Chem
, vol.282
, pp. 22023
-
-
Abbott, R.J.1
Spendlove, I.2
Roversi, P.3
-
46
-
-
30744459357
-
Modulation of Fas-mediated apoptosis by lipid rafts in T lymphocytes
-
Legembre P, Daburon S, Moreau P, Moreau JF, Taupin JL. Modulation of Fas-mediated apoptosis by lipid rafts in T lymphocytes. J Immunol 2006; 176:716.
-
(2006)
J Immunol
, vol.176
, pp. 716
-
-
Legembre, P.1
Daburon, S.2
Moreau, P.3
Moreau, J.F.4
Taupin, J.L.5
-
47
-
-
0033613826
-
T lymphocyte costimulation mediated by reorganization of membrane microdomains
-
Viola A, Schroeder S, Sakakibara Y, Lanzavecchia A. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science 1999; 283:680.
-
(1999)
Science
, vol.283
, pp. 680
-
-
Viola, A.1
Schroeder, S.2
Sakakibara, Y.3
Lanzavecchia, A.4
|